home / stock / igc / igc articles
Tuesday, IGC Pharma Inc (NYSE:IGC) released interim data from its Phase 2 clinical trial of IGC-AD1 for agitation in dementia associ...
As the Benzinga Cannabis Capital Conference gets underway in Florida, gathering top CEOs, investors and leaders in the cannabis industry, let'...
Wednesday, IGC Pharma Inc (NYSE:IGC) announced the results of an interim analysis of its ongoing Phase 2 trial of IGC-AD1 for Agitation i...
IGC Pharma, Inc. (NYSE American: IGC) has been granted European Patent No. 3193862 by the European Patent Office for its innovative "Cannabino...
News, Short Squeeze, Breakout and More Instantly...
India Globalization Capital Inc. Company Name:
IGC Stock Symbol:
NYSE Market:
Tuesday, IGC Pharma Inc (NYSE:IGC) released interim data from its Phase 2 clinical trial of IGC-AD1 for agitation in dementia associ...
As the Benzinga Cannabis Capital Conference gets underway in Florida, gathering top CEOs, investors and leaders in the cannabis industry, let'...
Wednesday, IGC Pharma Inc (NYSE:IGC) announced the results of an interim analysis of its ongoing Phase 2 trial of IGC-AD1 for Agitation i...